Crestor is a brand name for the drug rosuvastatin, which is used primarily to lower cholesterol levels and reduce the risk of cardiovascular disease. Developed and marketed by AstraZeneca, Crestor belongs to a class of medications known as statins. It works by inhibiting an enzyme involved in cholesterol production in the liver, thereby lowering LDL (bad cholesterol) and raising HDL (good cholesterol). First approved by the FDA in 2003, Crestor has been widely prescribed for managing high cholesterol, preventing heart attacks, and reducing the risk of stroke. Its brand reputation is bolstered by its effectiveness in significantly improving lipid profiles and its role in cardiovascular risk management